These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23052389)

  • 1. Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution.
    Cento V; Mirabelli C; Dimonte S; Salpini R; Han Y; Trimoulet P; Bertoli A; Micheli V; Gubertini G; Cappiello G; Spanò A; Longo R; Bernassola M; Mazzotta F; De Sanctis GM; Zhang XX; Verheyen J; D'Arminio Monforte A; Ceccherini-Silberstein F; Perno CF; Svicher V
    J Gen Virol; 2013 Jan; 94(Pt 1):143-149. PubMed ID: 23052389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2.
    Su M; Xiang K; Li Y; Li Y; Deng J; Xu X; Yan L; Zhuang H; Li T
    Infect Genet Evol; 2016 Jun; 40():275-281. PubMed ID: 27006281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.
    Martin CM; Welge JA; Shire NJ; Rouster SD; Shata MT; Sherman KE; Blackard JT
    J Viral Hepat; 2010 Aug; 17(8):588-97. PubMed ID: 19889143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.
    Weinberger KM; Bauer T; Böhm S; Jilg W
    J Gen Virol; 2000 May; 81(Pt 5):1165-74. PubMed ID: 10769057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
    Belyhun Y; Maier M; Liebert UG
    Antivir Ther; 2017; 22(2):97-111. PubMed ID: 27354181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus genetic diversity.
    Echevarría JM; Avellón A
    J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B.
    Aragri M; Alteri C; Battisti A; Di Carlo D; Minichini C; Sagnelli C; Bellocchi MC; Pisaturo MA; Starace M; Armenia D; Carioti L; Pollicita M; Salpini R; Sagnelli E; Perno CF; Coppola N; Svicher V
    J Infect Dis; 2016 Jun; 213(12):1897-905. PubMed ID: 26908731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
    Colagrossi L; Hermans LE; Salpini R; Di Carlo D; Pas SD; Alvarez M; Ben-Ari Z; Boland G; Bruzzone B; Coppola N; Seguin-Devaux C; Dyda T; Garcia F; Kaiser R; Köse S; Krarup H; Lazarevic I; Lunar MM; Maylin S; Micheli V; Mor O; Paraschiv S; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Simon F; Stanojevic M; Stene-Johansen K; Tihic N; Trimoulet P; Verheyen J; Vince A; Lepej SZ; Weis N; Yalcinkaya T; Boucher CAB; Wensing AMJ; Perno CF; Svicher V;
    BMC Infect Dis; 2018 Jun; 18(1):251. PubMed ID: 29859062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
    Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
    Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation--an insight from human immunodeficiency virus/hepatitis B virus coinfection.
    Mondal RK; Khatun M; Ghosh S; Banerjee P; Datta S; Sarkar S; Saha B; Santra A; Banerjee S; Chowdhury A; Datta S
    Clin Microbiol Infect; 2015 Jul; 21(7):710.e11-20. PubMed ID: 25882358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.
    Lee SY; Choi MS; Lee D; Lee JH; Koh KC; Paik SW; Yoo BC
    J Korean Med Sci; 2005 Jun; 20(3):433-7. PubMed ID: 15953865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.
    Lu HY; Zeng Z; Xu XY; Zhang NL; Yu M; Gong WB
    World J Gastroenterol; 2006 Jul; 12(26):4219-23. PubMed ID: 16830379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the S gene and in the overlapping reverse transcriptase region in chronic hepatitis B Chinese patients with coexistence of HBsAg and anti-HBs.
    Ding F; Miao XL; Li YX; Dai JF; Yu HG
    Braz J Infect Dis; 2016; 20(1):1-7. PubMed ID: 26613893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection.
    Tajik Z; Bokharaei-Salim F; Ghorbani S; Keyvani H; Esghaei M; Monavari SH; Ataei-Pirkooh A; Garshasbi S; Donyavi T; Fakhim A
    Arch Virol; 2018 Jun; 163(6):1559-1566. PubMed ID: 29476259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HIV-associated degree of immune suppression on molecular heterogeneity of hepatitis B virus among HIV co-infected patients.
    Pal A; Panigrahi R; Biswas A; Datta S; Sarkar N; Guha SK; Saha B; Banerjee A; Chakrabarti S; Chakravarty R
    Virology; 2013 Feb; 436(1):134-42. PubMed ID: 23228859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
    Colagrossi L; Salpini R; Scutari R; Carioti L; Battisti A; Piermatteo L; Bertoli A; Fabeni L; Minichini C; Trimoulet P; Fleury H; Nebuloso E; De Cristofaro M; Cappiello G; Spanò A; Malagnino V; Mari T; Barlattani A; Iapadre N; Lichtner M; Mastroianni C; Lenci I; Pasquazzi C; De Sanctis GM; Galeota Lanza A; Stanzione M; Stornaiuolo G; Marignani M; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Perno CF; Coppola N; Svicher V
    Viruses; 2018 Jul; 10(7):. PubMed ID: 29987240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic variations of hepatitis B virus strains in patients chronically coinfected with hepatitis B and human immunodeficiency viruses.
    Santos EA; Niel C; Vianna CO; De Sá CA; Gomes SA
    Acta Virol; 1998 Feb; 42(1):27-33. PubMed ID: 9645240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
    Belyhun Y; Liebert UG; Maier M
    PLoS One; 2018; 13(2):e0191970. PubMed ID: 29408943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.